BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cammarota G, Sanguinetti M, Gallo A, Posteraro B. Review article: biofilm formation by Helicobacter pylori as a target for eradication of resistant infection. Aliment Pharmacol Ther 2012;36:222-30. [DOI: 10.1111/j.1365-2036.2012.05165.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Lucio-Sauceda DG, Urrutia-Baca VH, Gomez-Flores R, De La Garza-Ramos MA, Tamez-Guerra P, Orozco-Flores A. Antimicrobial and Anti-Biofilm Effect of an Electrolyzed Superoxidized Solution at Neutral-pH against Helicobacter pylori. Biomed Res Int 2019;2019:6154867. [PMID: 31930132 DOI: 10.1155/2019/6154867] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Attaran B, Falsafi T, Moghaddam AN. Study of biofilm formation in C57Bl/6J mice by clinical isolates of Helicobacter pylori. Saudi J Gastroenterol. 2016;22:161-168. [PMID: 26997224 DOI: 10.4103/1319-3767.178529] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
3 Sierra F, Forero J, Rey M. Ideal treatment for Helicobacter pylori: A systematic review. Revista de Gastroenterología de México (English Edition) 2014;79:28-49. [DOI: 10.1016/j.rgmxen.2014.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Kanizaj TF, Kunac N. Helicobacter pylori: Future perspectives in therapy reflecting three decades of experience. World J Gastroenterol 2014; 20(3): 699-705 [PMID: 24574743 DOI: 10.3748/wjg.v20.i3.699] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
5 Hathroubi S, Servetas SL, Windham I, Merrell DS, Ottemann KM. Helicobacter pylori Biofilm Formation and Its Potential Role in Pathogenesis. Microbiol Mol Biol Rev 2018;82:e00001-18. [PMID: 29743338 DOI: 10.1128/MMBR.00001-18] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 9.8] [Reference Citation Analysis]
6 Cai J, Huang H, Song W, Hu H, Chen J, Zhang L, Li P, Wu R, Wu C. Preparation and evaluation of lipid polymer nanoparticles for eradicating H. pylori biofilm and impairing antibacterial resistance in vitro. International Journal of Pharmaceutics 2015;495:728-37. [DOI: 10.1016/j.ijpharm.2015.09.055] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
7 Yonezawa H, Osaki T, Kamiya S. Biofilm Formation by Helicobacter pylori and Its Involvement for Antibiotic Resistance. Biomed Res Int. 2015;2015:1-9. [PMID: 26078970 DOI: 10.1155/2015/914791] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
8 Fisher RA, Gollan B, Helaine S. Persistent bacterial infections and persister cells. Nat Rev Microbiol 2017;15:453-64. [DOI: 10.1038/nrmicro.2017.42] [Cited by in Crossref: 384] [Cited by in F6Publishing: 316] [Article Influence: 76.8] [Reference Citation Analysis]
9 Yoon H, Lee DH, Jang ES, Kim J, Shin CM, Park YS, Hwang JH, Kim JW, Jeong SH, Kim N. Effects of N-acetylcysteine on First-Line Sequential Therapy for Helicobacter pylori Infection: A Randomized Controlled Pilot Trial. Gut Liver 2016;10:520-5. [PMID: 26347514 DOI: 10.5009/gnl15048] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
10 García A, Salas-Jara MJ, Herrera C, González C. Biofilm and Helicobacter pylori: From environment to human host. World J Gastroenterol 2014; 20(19): 5632-5638 [PMID: 24914322 DOI: 10.3748/wjg.v20.i19.5632] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
11 Besednova NN, Zaporozhets TS, Somova LM, Kuznetsova TA. Review: prospects for the use of extracts and polysaccharides from marine algae to prevent and treat the diseases caused by Helicobacter pylori. Helicobacter 2015;20:89-97. [PMID: 25660579 DOI: 10.1111/hel.12177] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 5.9] [Reference Citation Analysis]
12 Li P, Chen X, Shen Y, Li H, Zou Y, Yuan G, Hu P, Hu H. Mucus penetration enhanced lipid polymer nanoparticles improve the eradication rate of Helicobacter pylori biofilm. J Control Release 2019;300:52-63. [PMID: 30825476 DOI: 10.1016/j.jconrel.2019.02.039] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
13 Windham IH, Servetas SL, Whitmire JM, Pletzer D, Hancock REW, Merrell DS. Helicobacter pylori Biofilm Formation Is Differentially Affected by Common Culture Conditions, and Proteins Play a Central Role in the Biofilm Matrix. Appl Environ Microbiol 2018;84:e00391-18. [PMID: 29752266 DOI: 10.1128/AEM.00391-18] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
14 Cellini L. Helicobacter pylori: A chameleon-like approach to life. World J Gastroenterol 2014; 20(19): 5575-5582 [PMID: 24914317 DOI: 10.3748/wjg.v20.i19.5575] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
15 Zhang L, Wu WKK, Gallo RL, Fang EF, Hu W, Ling TKW, Shen J, Chan RLY, Lu L, Luo XM, Li MX, Chan KM, Yu J, Wong VWS, Ng SC, Wong SH, Chan FKL, Sung JJY, Chan MTV, Cho CH. Critical Role of Antimicrobial Peptide Cathelicidin for Controlling Helicobacter pylori Survival and Infection. J I 2016;196:1799-809. [DOI: 10.4049/jimmunol.1500021] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
16 Xiao S, Shang K, Zhang L, Li W, Wang X. A rapid anti-Helicobacter pylori biofilm drug screening biosensor based on AlpB outer membrane protein and colloidal gold/nanoporous gold framework. Biosensors and Bioelectronics 2022. [DOI: 10.1016/j.bios.2022.114599] [Reference Citation Analysis]
17 Caliskan R, Tokman HB, Erzin Y, Saribas S, Yuksel P, Bolek BK, Sevuk EO, Demirci M, Yılmazli O, Akgul O, Kalayci F, Cakan H, Salih B, Bal K, Kocazeybek B. Antimicrobial resistance of Helicobacter pylori strains to five antibiotics, including levofloxacin, in Northwestern Turkey. Rev Soc Bras Med Trop 2015;48:278-84. [PMID: 26108005 DOI: 10.1590/0037-8682-0027-2015] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
18 Spiegel M, Krzyżek P, Dworniczek E, Adamski R, Sroka Z. In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against Helicobacter pylori. Molecules 2021;27:20. [PMID: 35011255 DOI: 10.3390/molecules27010020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Yoon H, Lee DH. Mucolytics as Adjuvant Agent to Improve Helicobacter pylori Eradication Rate: Still Long and Winding Road to Positive Results. Gut Liver 2015;9:257-8. [PMID: 25918255 DOI: 10.5009/gnl15117] [Reference Citation Analysis]
20 Fontes LES, Martimbianco ALC, Zanin C, Riera R. N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication. Cochrane Database Syst Rev. 2019;2:CD012357. [PMID: 30746681 DOI: 10.1002/14651858.cd012357.pub2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
21 Arif M, Sharaf M, Samreen, Khan S, Chi Z, Liu CG. Chitosan-based nanoparticles as delivery-carrier for promising antimicrobial glycolipid biosurfactant to improve the eradication rate of Helicobacter pylori biofilm. J Biomater Sci Polym Ed 2021;32:813-32. [PMID: 33428545 DOI: 10.1080/09205063.2020.1870323] [Reference Citation Analysis]
22 Percival SL, Williams DW. Helicobacter pylori. Microbiology of Waterborne Diseases. Elsevier; 2014. pp. 119-54. [DOI: 10.1016/b978-0-12-415846-7.00007-x] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
23 Emami MH, Zobeiri M, Rahimi H, Arjomandi F, Daghagzadeh H, Adibi P, Hashemi J. N-acetyl cysteine as an adjunct to standard anti-Helicobacter pylori eradication regimen in patients with dyspepsia: A prospective randomized, open-label trial. Adv Biomed Res 2014;3:189. [PMID: 25298958 DOI: 10.4103/2277-9175.140403] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
24 Wong EH, Ng CG, Chua EG, Tay AC, Peters F, Marshall BJ, Ho B, Goh KL, Vadivelu J, Loke MF. Comparative Genomics Revealed Multiple Helicobacter pylori Genes Associated with Biofilm Formation In Vitro. PLoS One. 2016;11:e0166835. [PMID: 27870886 DOI: 10.1371/journal.pone.0166835] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
25 Hu B, Zhao F, Wang S, Olszewski MA, Bian H, Wu Y, Kong M, Xu L, Miao Y, Fang Y, Yang C, Zhao H, Zhang Y. A high-throughput multiplex genetic detection system for Helicobacter pylori identification, virulence and resistance analysis. Future Microbiol 2016;11:1261-78. [PMID: 27023051 DOI: 10.2217/fmb-2016-0023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
26 Orta de Velásquez MT, Yáñez Noguez I, Casasola Rodríguez B, Román Román PI. Effects of ozone and chlorine disinfection on VBNC Helicobacter pylori by molecular techniques and FESEM images. Environ Technol 2017;38:744-53. [PMID: 27432258 DOI: 10.1080/09593330.2016.1210680] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
27 Zhang Y, Zhao F, Kong M, Wang S, Nan L, Hu B, Olszewski MA, Miao Y, Ji D, Jiang W, Fang Y, Zhang J, Chen F, Xiang P, Wu Y, Zhao H. Validation of a High-Throughput Multiplex Genetic Detection System for Helicobacter pylori Identification, Quantification, Virulence, and Resistance Analysis. Front Microbiol 2016;7:1401. [PMID: 27656172 DOI: 10.3389/fmicb.2016.01401] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
28 Yonezawa H, Osaki T, Hanawa T, Kurata S, Ochiai K, Kamiya S. Impact of Helicobacter pylori biofilm formation on clarithromycin susceptibility and generation of resistance mutations. PLoS One. 2013;8:e73301. [PMID: 24039906 DOI: 10.1371/journal.pone.0073301] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
29 Yonezawa H, Osaki T, Fukutomi T, Hanawa T, Kurata S, Zaman C, Hojo F, Kamiya S. Diversification of the AlpB Outer Membrane Protein of Helicobacter pylori Affects Biofilm Formation and Cellular Adhesion. J Bacteriol 2017;199:e00729-16. [PMID: 28031283 DOI: 10.1128/JB.00729-16] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
30 Meng F, Tao H, Mi Y, Yang T, Wang X, Go Y, Lin Y, Wang G. Nanocluster-mediated photothermia improves eradication efficiency and antibiotic sensitivity of Helicobacter pylori. Cancer Nano 2022;13. [DOI: 10.1186/s12645-022-00121-2] [Reference Citation Analysis]
31 Adebisi AO, Conway BR. Modification of drug delivery to improve antibiotic targeting to the stomach. Ther Deliv 2015;6:741-62. [PMID: 26149788 DOI: 10.4155/tde.15.35] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
32 Yu M, Wang X, Ling F, Wang H, Zhang P, Shao S. Atractylodes lancea volatile oils attenuated helicobacter pylori NCTC11637 growth and biofilm. Microb Pathog 2019;135:103641. [PMID: 31330262 DOI: 10.1016/j.micpath.2019.103641] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
33 Trastoy R, Manso T, Fernández-García L, Blasco L, Ambroa A, Pérez Del Molino ML, Bou G, García-Contreras R, Wood TK, Tomás M. Mechanisms of Bacterial Tolerance and Persistence in the Gastrointestinal and Respiratory Environments. Clin Microbiol Rev 2018;31:e00023-18. [PMID: 30068737 DOI: 10.1128/CMR.00023-18] [Cited by in Crossref: 61] [Cited by in F6Publishing: 36] [Article Influence: 15.3] [Reference Citation Analysis]
34 Shen Y, Li P, Chen X, Zou Y, Li H, Yuan G, Hu H. Activity of Sodium Lauryl Sulfate, Rhamnolipids, and N-Acetylcysteine Against Biofilms of Five Common Pathogens. Microb Drug Resist 2020;26:290-9. [PMID: 31211651 DOI: 10.1089/mdr.2018.0385] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Fauzia KA, Miftahussurur M, Syam AF, Waskito LA, Doohan D, Rezkitha YAA, Matsumoto T, Tuan VP, Akada J, Yonezawa H, Kamiya S, Yamaoka Y. Biofilm Formation and Antibiotic Resistance Phenotype of Helicobacter pylori Clinical Isolates. Toxins (Basel) 2020;12:E473. [PMID: 32722296 DOI: 10.3390/toxins12080473] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
36 Noble ML, Mourad PD, Ratner BD. Digital Drug Delivery: On-Off Ultrasound Controlled Antibiotic Release from Coated Matrices with Negligible Background Leaching. Biomater Sci 2014;2:839-902. [PMID: 25045519 DOI: 10.1039/C3BM60203F] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 1.9] [Reference Citation Analysis]
37 Gong Y, Yuan Y. Resistance mechanisms of Helicobacter pylori and its dual target precise therapy. Crit Rev Microbiol. 2018;44:371-392. [PMID: 29293032 DOI: 10.1080/1040841x.2017.1418285] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
38 Adebisi AO, Conway BR. Lectin-conjugated microspheres for eradication of Helicobacter pylori infection and interaction with mucus. International Journal of Pharmaceutics 2014;470:28-40. [DOI: 10.1016/j.ijpharm.2014.04.070] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
39 Debraekeleer A, Remaut H. Future perspective for potential Helicobacter pylori eradication therapies. Future Microbiology 2018;13:671-87. [DOI: 10.2217/fmb-2017-0115] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
40 Chen X, Zou Y, Zhang S, Fang P, Li S, Li P, Sun Y, Yuan G, Hu H. Multi-functional vesicles improve Helicobacter pylori eradication by a comprehensive strategy based on complex pathological microenvironment. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.05.014] [Reference Citation Analysis]
41 Sierra F, Forero JD, Rey M, Botero ML, Cárdenas A. Pilot study: miscellaneous therapy is highly successful for Helicobacter pylori eradication. Aliment Pharmacol Ther. 2013;37:1165-1171. [PMID: 23656465 DOI: 10.1111/apt.12329] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
42 Sierra F, Forero JD, Rey M. [Ideal treatment for Helicobacter pylori: a systematic review]. Rev Gastroenterol Mex 2014;79:28-49. [PMID: 24365458 DOI: 10.1016/j.rgmx.2013.03.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
43 Aly MA, Domig KJ, Kneifel W, Reimhult E. Whole Genome Sequencing-Based Comparison of Food Isolates of Cronobacter sakazakii. Front Microbiol 2019;10:1464. [PMID: 31333604 DOI: 10.3389/fmicb.2019.01464] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
44 Salillas S, Sancho J. Flavodoxins as Novel Therapeutic Targets against Helicobacter pylori and Other Gastric Pathogens. Int J Mol Sci 2020;21:E1881. [PMID: 32164177 DOI: 10.3390/ijms21051881] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
45 Maiorana A, Bugli F, Papi M, Torelli R, Ciasca G, Maulucci G, Palmieri V, Cacaci M, Paroni Sterbini F, Posteraro B, Sanguinetti M, De Spirito M. Effect of Alginate Lyase on Biofilm-Grown Helicobacter pylori Probed by Atomic Force Microscopy. International Journal of Polymer Science 2015;2015:1-9. [DOI: 10.1155/2015/989516] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
46 Jahani Moghadam F, Navidifar T, Amin M. Antibacterial Activity of Garlic (Allium sativum L.) on Multi-Drug Resistant Helicobacter pylori Isolated From Gastric Biopsies. Int J Enteric Pathog 2014;2. [DOI: 10.17795/ijep16749] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
47 Attaran B, Falsafi T, Ghorbanmehr N. Effect of biofilm formation by clinical isolates of Helicobacter pylori on the efflux-mediated resistance to commonly used antibiotics. World J Gastroenterol 2017; 23(7): 1163-1170 [PMID: 28275296 DOI: 10.3748/wjg.v23.i7.1163] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
48 Paluch E, Szperlik J, Lamch Ł, Wilk KA, Obłąk E. Biofilm eradication and antifungal mechanism of action against Candida albicans of cationic dicephalic surfactants with a labile linker. Sci Rep 2021;11:8896. [PMID: 33903615 DOI: 10.1038/s41598-021-88244-1] [Reference Citation Analysis]
49 Wang Y, Guo X, Zhou S, Wang L, Fang Y, Xing L, Zhao Y, Zhang LP, Qiu H, Zeng J, Gu Y. Selective photodynamic inactivation of Helicobacter pylori by a cationic benzylidene cyclopentanone photosensitizer - an in vitro and ex vivo study. J Photochem Photobiol B 2021;223:112287. [PMID: 34454316 DOI: 10.1016/j.jphotobiol.2021.112287] [Reference Citation Analysis]
50 Adebisi AO, Laity PR, Conway BR. Formulation and evaluation of floating mucoadhesive alginate beads for targeting Helicobacter pylori. J Pharm Pharmacol 2015;67:511-24. [PMID: 25496042 DOI: 10.1111/jphp.12345] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
51 Bugli F, Palmieri V, Torelli R, Papi M, De Spirito M, Cacaci M, Galgano S, Masucci L, Paroni Sterbini F, Vella A, Graffeo R, Posteraro B, Sanguinetti M. In vitro effect of clarithromycin and alginate lyase against helicobacter pylori biofilm. Biotechnol Prog 2016;32:1584-91. [PMID: 27535356 DOI: 10.1002/btpr.2339] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
52 Cárdenas-Mondragón MG, Ares MA, Panunzi LG, Pacheco S, Camorlinga-Ponce M, Girón JA, Torres J, De la Cruz MA. Transcriptional Profiling of Type II Toxin-Antitoxin Genes of Helicobacter pylori under Different Environmental Conditions: Identification of HP0967-HP0968 System. Front Microbiol 2016;7:1872. [PMID: 27920769 DOI: 10.3389/fmicb.2016.01872] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
53 Luo P, Huang Y, Hang X, Tong Q, Zeng L, Jia J, Zhang G, Bi H. Dihydrotanshinone I Is Effective against Drug-Resistant Helicobacter pylori In Vitro and In Vivo. Antimicrob Agents Chemother 2021;65:e01921-20. [PMID: 33318002 DOI: 10.1128/AAC.01921-20] [Reference Citation Analysis]
54 Bessa LJ, Grande R, Iorio DD, Giulio MD, Campli ED, Cellini L. Helicobacter pylori free-living and biofilm modes of growth: behavior in response to different culture media. APMIS 2013;121:549-60. [DOI: 10.1111/apm.12020] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
55 Chen CC, Luo JC, Fang YJ, Lee JY, Kuo CC, Yang TH, Chiu MC, Yu JJ, Bair MJ, Chen PY, Chou CK, Chen CY, Chang CY, Hsu YC, Tseng CH, Hsu WF, Hu WH, Tsai MH, Hsieh CL, Chen MJ, Shun CT, Liu TY, Lee YC, Liou JM, Wu MS; and for the Taiwan Gastrointestinal Disease and Helicobacter Consortium. Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial. Therap Adv Gastroenterol 2020;13:1756284820927306. [PMID: 32821287 DOI: 10.1177/1756284820927306] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
56 Prasad A, Devi AT, Prasad MNN, Zameer F, Shruthi G, Shivamallu C. Phyto anti-biofilm elicitors as potential inhibitors of Helicobacter pylori. 3 Biotech 2019;9:53. [PMID: 30729077 DOI: 10.1007/s13205-019-1582-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
57 Jia J, Zhang C, Liu Y, Huang Y, Bai Y, Hang X, Zeng L, Zhu D, Bi H. Armeniaspirol A: a novel anti-Helicobacter pylori agent. Microb Biotechnol 2021. [PMID: 33780131 DOI: 10.1111/1751-7915.13807] [Reference Citation Analysis]
58 Rasmussen K, Nikrad J, Reilly C, Li Y, Jones RS. N-Acetyl-l-cysteine effects on multi-species oral biofilm formation and bacterial ecology. Lett Appl Microbiol 2016;62:30-8. [PMID: 26518358 DOI: 10.1111/lam.12513] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
59 Darmani H, Smadi EAM, Bataineh SMB. Blue light emitting diodes enhance the antivirulence effects of Curcumin against Helicobacter pylori. J Med Microbiol 2020;69:617-24. [PMID: 32100708 DOI: 10.1099/jmm.0.001168] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
60 Pan-in P, Tachapruetinun A, Chaichanawongsaroj N, Banlunara W, Suksamrarn S, Wanichwecharungruang S. Combating Helicobacter pylori infections with mucoadhesive nanoparticles loaded with Garcinia mangostana extract. Nanomedicine 2014;9:457-68. [DOI: 10.2217/nnm.13.30] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
61 Chen X, Li P, Shen Y, Zou Y, Yuan G, Hu H. Rhamnolipid-involved antibiotics combinations improve the eradication of Helicobacter pylori biofilm in vitro: A comparison with conventional triple therapy. Microbial Pathogenesis 2019;131:112-9. [DOI: 10.1016/j.micpath.2019.04.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
62 Lewinska A, Wnuk M. Helicobacter pylori-induced premature senescence of extragastric cells may contribute to chronic skin diseases. Biogerontology 2017;18:293-9. [PMID: 28074309 DOI: 10.1007/s10522-017-9676-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]